Catalyst
Slingshot members are tracking this event:
PDUFA Date Expected in July 2017 for Puma Bio's (PBYI) Neratinib in Extended Adjuvant Treatment of Patients with Early-Stage HER2+ Breast Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PBYI |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 17, 2017
Occurred Source:
http://www.pumabiotechnology.com/pr20170717.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pdufa Date, Neratinib, Extended Adjuvant Treatment, Early-stage Her2+, Breast Cancer